IP Library Granted Patent US 8,050,769
Granted Patent B2
US 8,050,769 · App. 12/434,303 · Granted Nov 1, 2011

System and methods for determining nerve proximity, direction, and pathology during surgery

Assignee: NuVasive, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,050,769
App. No.
12/434,303
Filed
May 1, 2009
Granted
Nov 1, 2011
Kind
B2
Art Unit
3762
USPC
607/48
Abstract

The present invention involves systems and methods for determining nerve proximity, nerve direction, and pathology relative to a surgical instrument based on an identified relationship between neuromuscular responses and the stimulation signal that caused the neuromuscular responses.

Claims (32)

1. A surgical system for stimulating nerves and monitoring EMG responses to the nerve simulation, comprising:

a control unit configured to receive user input regarding delivery of a stimulation signal and configured to receive neuromuscular response data, the control unit including a color display device and being configured to compute information for output to the color display device, said information being indicative of two or more of: nerve proximity, nerve direction, nerve pathology, stimulation level, EMG response data, pedicle integrity, advance or hold instructions, and instrument in use, wherein the color display device provides an evoked potentials display option that shows the voltage waveforms for a plurality of EMG response channels;

a connector module that comprises a plurality of EMG response channels and an electrical connection for at least one nerve stimulation instrument, the connector module having a wire connection to the control unit so that the connector module is positionable apart from the control unit;

a plurality of pairs of EMG electrodes connectable to the plurality of EMG response channels of the connector module, the EMG electrodes being mountable proximate to selected leg muscles;

a first stimulation instrument comprising a dilator tube and a stimulation element that delivers the stimulation signal proximate to a distal end of the dilator tube when the dilator tube is advanced through tissue in a path toward a spine; and

a second stimulation instrument comprising a pedicle probe that delivers the stimulation signal when advanced into a pedicle opening formed in the spine, wherein the pedicle probe comprises a probe tip member and handle with a user-actuatable button to activate the stimulation signal for delivery by the screw test probe.

2. The system of claim 1 , further comprising one or more sequential dilator cannulas that are deliverable through the tissue in the path toward the spine.

3. The system of claim 1 , further comprising an operative corridor instrument that is deliverable over the one or more sequential dilator cannulas when advanced toward the spine.

4. The system of claim 3 , wherein the operative corridor instrument comprises a working cannula that defines a tubular corridor to access the spine when the working cannula is advanced to the spine.

5. The system of claim 1 , wherein the stimulation element of the first stimulation instrument comprises an obturator arranged inside the dilator tube and equipped with one or more stimulation electrodes.

6. The system of claim 5 , further comprising a guide wire that is insertable through the dilator tube when the obturator is removed from the dilator tube, the guide wire being insertable through the dilator tube and into an annulus of a disc of the spine.

7. The system of claim 5 , wherein the connector module comprises eight EMG response channels.

8. The system of claim 7 , wherein the plurality of pairs of EMG electrodes is eight pairs of EMG electrodes connectable to the eight EMG response channels.

9. The system of claim 8 , further comprising an anode electrode to provide a return path for the stimulation signal and a common electrode.

10. The system of claim 1 , wherein the control unit is configured to represent each of the plurality of EMG response channels on the color display device with a different color.

11. The system of claim 10 , wherein the control unit is configured to indicate a preferred muscle location for each of the plurality of EMG electrodes on the color display device.

12. The system of claim 11 , wherein the control unit is configured to indicate the preferred muscle location on the color display device using text associated with each channel.

13. The system of claim 11 , wherein the control unit is configured to indicate the preferred muscle location on the color display device using an image of the human form.

14. The system of claim 10 , wherein the control unit is configured to receive input of a selection of a channel tab associated with a specific EMG channel, and the control unit is configured to highlight on the color display device the preferred placement of the pair of EMG electrodes associated with the selected channel on an image of the human form and displays the name of the muscle monitored by the selected channel.

15. The system of claim 14 , wherein the control unit is configured to output data for display on the color display device indicative of the spinal levels associated with the selected channel.

16. The system of claim 1 , wherein the control unit further determines a relationship between stimulation signals and the neuromuscular response data to indicate at least one of nerve proximity, nerve direction, nerve pathology.

17. The system of claim 16 , wherein the relationship determined is the threshold stimulation current required to evoke an EMG response greater than a predetermined minimum amplitude.

18. The system of claim 17 , wherein the control unit automatically adjusts the magnitude of successive stimulation signals until the threshold stimulation current is determined.

19. The system of claim 18 , wherein the control unit automatically adjusts the magnitude of successive stimulation signals by larger increments until a first bracket having a first width containing said threshold is determined, and thereafter automatically adjusts the magnitude of successive stimulation signals until a second bracket having a second width smaller than said first width and containing said stimulation threshold is determined.

20. The system of claim 19 , wherein the predetermined minimum amplitude of the EMG response is 100 μV.

21. The system of claim 17 , wherein the control unit is configured to output the value of the determined stimulation threshold for display on the color display device.

22. The system of claim 21 , wherein the control unit displays a color determined by the threshold stimulation current determined.

23. The system of claim 22 , wherein the control unit determines the threshold stimulation current for each of the plurality of EMG response channels.

24. The system of claim 23 , wherein the control unit determines the threshold stimulation current on the EMG response channel having the lowest stimulation threshold current first.

25. The system of claim 1 , wherein the color display comprises a touchscreen display.

26. The system of claim 25 , wherein the touchscreen display is operable to receive user commands.

27. The system of claim 2 , wherein at least one of the sequential dilator cannulas is connectable to the connector module and includes a stimulation element that delivers the stimulation signal proximate to a distal end of the at least one sequential dilator cannula when the at least one sequential dilator cannula is delivered through the tissue in the path toward the spine.

Assignments (4)
SECURITY INTEREST Recorded Feb 28, 2020
From: NUVASIVE, INC.; NUVASIVE CLINICAL SERVICES MONITORING, INC.; NUVASIVE CLINICAL SERVICES, INC.; NUVASIVE SPECIALIZED ORTHOPEDICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 052918/0595 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded May 17, 2017
From: NUVASIVE, INC.; BIOTRONIC NATIONAL, LLC; NUVASIVE CLINICAL SERVICES MONITORING, INC.; NUVASIVE CLINICAL SERVICES, INC.; NUVASIVE SPECIALIZED ORTHOPEDICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 042490/0236 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Nov 16, 2016
From: NUVASIVE, INC.; IMPULSE MONITORING, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 040634/0404 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2011
From: KAULA, NORBERT; GHARIB, JAMES; MEDEIROS, GORETTI; FARQUHAR, ALLEN
To: NUVASIVE, INC.
Reel/Frame 025833/0163 →
Continuity (3)
Continuation 10754899 · Jan 9, 2004
Continuation PCTUS0222247 · Jul 11, 2002
Related Publication 20090209879A1 · Aug 20, 2009